Welcome to the Microbiome Research Group

The mission of the Microbiome Research Group is to conduct large-scale, applied, and product-oriented research in the field of endocrine and metabolic diseases. The group prioritizes the development of standardized and localized operational guidelines in the field of the microbiome. Securing financial support from various institutions and entering into national and international cooperation agreements to provide the necessary infrastructure are among the other missions of this group. Leading major national projects to achieve a model of the Iranian microbiome in different age and gender groups, ethnicities, and geographical regions of the country is one of the goals of the Microbiome Research Group. We strive to utilize the knowledge gained in the field of the microbiome for therapeutic interventions.

The Microbiome Research Group aims to advance the understanding of the human microbiome and its intricate relationship with endocrine and metabolic diseases. Our research focuses on:

• Conducting high-quality, translational research to bridge the gap between basic science and clinical applications.
• Developing and validating novel methodologies for microbiome analysis, including high-throughput sequencing, metagenomics, and metabolomics.
• Characterizing the human microbiome in diverse Iranian populations, considering factors such as age, gender, ethnicity, geography, and lifestyle. This includes establishing a comprehensive database of the Iranian microbiome.
• Investigating the role of the microbiome in the pathogenesis of endocrine and metabolic disorders, such as obesity, type 2 diabetes, non-alcoholic fatty liver disease, and cardiovascular disease.
• Exploring the potential of microbiome-based therapies, including probiotics, prebiotics, fecal microbiota transplantation, and microbiome-modulating drugs.
• Developing and implementing standardized operating procedures for microbiome research to ensure data quality and reproducibility.
• Fostering national and international collaborations to advance the field of microbiome research and facilitate knowledge exchange.
• Disseminating research findings through high-impact publications and presentations at scientific conferences.